⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butane SCHEMBL27301811 | 0.90 | ALDH1A1 (0.30) | — | |
| Alcohol SCHEMBL94631 | 0.90 | ALDH1A1 (0.40) | — | |
| Alcohol SCHEMBL10857495 | 0.87 | ALDH1A1 (0.38) | — | |
| Ethylamine SCHEMBL5718050 | 0.87 | — | — | |
| Alcohol SCHEMBL10862814 | 0.87 | ALDH1A1 (0.38) | — | |
| Alcohol SCHEMBL2508797 | 0.87 | ALDH1A1 (0.38) | — | |
| Alcohol SCHEMBL8604617 | 0.87 | ALDH1A1 (0.38) | — | |
| Alcohol SCHEMBL639197 | 0.87 | ALDH1A1 (0.38) | — | |
| Methyl Alcohol SCHEMBL30632902 | 0.85 | — | — | |
| Ethane SCHEMBL2560568 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117897379-A | Process for the synthesis of naphthyridine derivatives and intermediates thereof | 美国安进公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117597337-A | Process for the preparation of antibacterial compounds | 迪斯库瓦有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-110997645-B | Preparation method of ozagrel | 埃吉斯制药公司 | 2023-10-10 | — | — | CN | claimed |
| CN-116096711-A | Herbicidal compounds | 先正达农作物保护股份公司 | 2023-05-09 | — | — | CN | claimed |
| CN-115485269-A | Ring-closure synthesis of macrocyclic MCL-1 inhibitor intermediates | 安进公司 | 2022-12-16 | — | — | CN | claimed |
| CN-113412254-A | Pyrazole derivatives | 先正达农作物保护股份公司 | 2021-09-17 | — | — | CN | claimed |
| CN-112088003-A | Process for preparing pyrimidinyl-4-aminopyrazole compounds | 戴纳立制药公司 | 2020-12-15 | — | — | CN | claimed |
| CN-110997645-A | Preparation method of ozanimod | 埃吉斯制药公司 | 2020-04-10 | — | — | CN | claimed |
| US-9371287-B2 | Process for making modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-06-21 | — | — | US | claimed |
| US-8835639-B2 | Process for making modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-09-16 | — | — | US | claimed |
| US-8754222-B2 | Process for preparing modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-06-17 | — | — | US | claimed |
| US-8476442-B2 | Process for making modulators of cystic fibrosis transmembrane conductance regulator | VERTEX PHARMACEUTICAL INCORPORATED (US) | 2013-07-02 | — | — | US | claimed |
| US-12227713-B2 | Polysiloxane hydraulic fluids | THE BOEING COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| US-20250011671-A9 | POLYSILOXANE HYDRAULIC FLUIDS | THE BOEING COMPANY | 2025-01-09 | — | — | US | disclosed |
| CN-114805365-B | Factor XIA new macrocycles carrying non-aromatic P2' groups | 百时美施贵宝公司 | 2024-07-23 | — | — | CN | disclosed |
| CN-118344370-A | Isoindolinone and indazole compounds for EGFR degradation | C4医药公司 | 2024-07-16 | — | — | CN | disclosed |
| US-5430151-A | Treatment of aids, pneumonia, caprine arthritis encephalitis, leukemia and immmunodeficiency | BAYER AKTIENGESELLSCHAFT (DE) | 1995-07-04 | — | — | US | disclosed |
| US-5201932-A | Herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-13 | — | — | US | disclosed |
| US-5185324-A | ENZYME-INHIBITING AMINO ACID DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF, AGENTS CONTAINING THESE, AND THE USE THEREOF | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-02-09 | — | — | US | disclosed |
| US-5169841-A | Enzyme inhibitors, hypotensive agents, high enteral bioauailability | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-12-08 | — | — | US | disclosed |